BioCentury
ARTICLE | Management Tracks

Roche veteran Chow becomes head of China & international at Merck KGaA

Plus: Bayer, Bluerock, Qiming, Editas and more

July 27, 2021 1:13 AM UTC

Hong Chow will join the healthcare business sector of Merck KGaA (Xetra:MRK) as head of China & international, effective Oct. 1. Chow previously served as CEO of Roche (SIX:ROG; OTCQX:RHHBY) Pharmaceuticals China for more than six years. 

Bayer AG (Xetra:BAYN) named Dominik Ruettinger as head of research and early development for oncology at its pharmaceutical division, effective Oct.1. Ruettinger was most recently SVP, global head of oncology at Roche...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article